FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for Effexor XR (venlafaxine extended-release) submitted by Viatris Specialty LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Major Depressive Disorder
• Panic Disorder
• Social Anxiety Disorder

Drugs mentioned

• Effexor XR (venlafaxine)

Snippet

SUPPL AP for EFFEXOR XR (VENLAFAXINE HYDROCHLORIDE)